Jefferies Group's LEGN Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 10,000 shares of Legend Biotech Corporation (LEGN) worth $217,400, representing 0.00% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Jefferies Group has maintained this position in LEGN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2024, adding 16,500 shares. Largest reduction occurred in Q1 2024, reducing 19,250 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Legend Biotech Corporation (LEGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Legend Biotech Corporation (LEGN) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +10,000 | New Buy | 10,000 | $21.74 |
| Q4 2024 | -7,500 | Sold Out | 0 | $0.00 |
| Q3 2024 | -9,000 | Reduce 54.55% | 7,500 | $48.73 |
| Q2 2024 | +16,500 | New Buy | 16,500 | $44.29 |
| Q1 2024 | -19,250 | Sold Out | 0 | $0.00 |
| Q4 2023 | +19,250 | New Buy | 19,250 | $60.17 |
Jefferies Group's Legend Biotech Corporation Investment FAQs
Jefferies Group first purchased Legend Biotech Corporation (LEGN) in Q4 2023, acquiring 19,250 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Legend Biotech Corporation (LEGN) for 6 quarters since Q4 2023.
Jefferies Group's largest addition to Legend Biotech Corporation (LEGN) was in Q4 2023, adding 19,250 shares worth $1.16 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 10,000 shares of Legend Biotech Corporation (LEGN), valued at approximately $217,400.
As of the Q4 2025 filing, Legend Biotech Corporation (LEGN) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Legend Biotech Corporation (LEGN) was 19,250 shares, as reported at the end of Q4 2023.